Latest DEF 14A proxy statements

Weis Markets' latest proxy statement outlines proposals for its 2026 Annual Meeting, including director elections, auditor ratification, and executive compensation votes, while disclosing a financial restatement leading to executive pay clawbacks.

Avanos Medical, Inc. announces its 2026 Annual Meeting of Stockholders to address director elections, auditor ratification, executive compensation, and an amendment to its long-term incentive plan.

Public Service Enterprise Group (PSEG) announces its 2026 Annual Meeting agenda, including director elections, executive compensation approval, and proposals to eliminate supermajority voting requirements.

Healthpeak Properties, Inc. reports solid 2025 financial and operational performance, including a 4% same-store NOI growth, and announces the planned IPO of its senior housing portfolio as Janus Living, Inc.

Community Healthcare Trust Incorporated announces its 2026 annual meeting agenda, including director elections, executive compensation votes, and details on recent financial performance and compensation adjustments.

Amrize Ltd, following its spin-off from Holcim, reports mixed financial results for fiscal year 2025, proposes special and regular dividends, and outlines key governance and compensation matters for its upcoming Annual General Meeting.

Charter Communications, Inc. announces its 2026 Annual Meeting of Stockholders to vote on director elections, an increase in its stock incentive plan, executive compensation, and auditor ratification.

Getty Realty Corp. announces its 2026 Annual Meeting of Stockholders to address director elections, executive compensation, and auditor ratification, alongside reporting strong 2025 financial and investment performance.

LCNB Corp. announced its 2026 Annual Meeting of Shareholders will be held virtually on April 27, 2026, to elect directors, vote on executive compensation, and ratify its independent auditor.

Arts-Way Manufacturing Co., Inc. announced its 2026 Annual Meeting of Stockholders to vote on director elections, auditor ratification, an equity plan increase, and executive compensation.

DTE Energy's latest proxy statement highlights significant 2025 operational and financial achievements, including grid modernization, clean energy expansion, and strong shareholder returns, while outlining strategic priorities for 2026.

Stock Yards Bancorp reported record net income and EPS for 2025, driven by robust loan and deposit growth, and announced its virtual 2026 Annual Meeting of Shareholders.

Nexentis Technologies Inc. calls a special meeting to approve a reverse stock split, a discounted equity issuance, and an expanded credit facility to maintain Nasdaq listing and fund operations.

Putnam Managed Municipal Income Trust and related funds filed an amended proxy statement to correct proposals for their April 17, 2026 Annual Shareholder Meeting.

Putnam's closed-end funds filed an amended proxy statement to correct proxy card details for their upcoming April 17, 2026, annual shareholder meeting, focusing on trustee elections and board size.

Putnam's closed-end funds filed an amended proxy statement to correct proxy card details for their upcoming April 17, 2026, annual shareholder meeting, focusing on trustee elections and board size.

Putnam Managed Municipal Income Trust and related funds filed an amended proxy statement to correct proposals for their April 17, 2026 Annual Shareholder Meeting.

Equity Bancshares, Inc. announced its 2026 Annual Meeting of Stockholders to be held on April 21, 2026, to vote on director elections, executive compensation, an equity plan amendment, and auditor ratification.

Equity Bancshares, Inc. announces its 2026 Annual Meeting agenda, highlighting strong 2025 adjusted financial results, strategic acquisitions, and a proposed increase in its equity incentive plan shares.

UMB Financial Corporation announces record 2025 financial performance driven by the HTLF acquisition and outlines key proposals for its upcoming 2026 Annual Shareholder Meeting.

Huntington Bancshares Incorporated announces its 2026 Annual Meeting of Shareholders, detailing director elections, executive compensation, and auditor ratification.

Pfizer Inc. has filed a Definitive Proxy Statement (DEFA14A) with the SEC, signaling upcoming shareholder matters.

Huntington Bancshares reports a transformational 2025 with 11% revenue growth, significant organic loan and deposit expansion, and strategic mergers positioning it as a top-10 U.S. bank.

Pfizer reported a 2% operational revenue decline in 2025 but highlighted 6% ex-COVID growth, significant cost savings, and strategic pipeline advancements, while addressing executive compensation concerns.

AGCO Corporation has filed its definitive proxy statement (DEFA14A) with the U.S. Securities and Exchange Commission.

Texas Capital Bancshares, Inc. has filed a Definitive Proxy Statement (DEFA14A) with the SEC.

Texas Capital Bancshares, Inc. announces its 2026 Annual Meeting agenda, featuring a proposal to redomicile from Delaware to Texas, alongside reporting record 2025 financial performance and board refreshment initiatives.

AGCO Corporation's latest proxy statement reveals a focus on strategic growth initiatives, strong cash flow generation despite a challenging agricultural market, and robust corporate governance practices.

West Pharmaceutical Services, Inc. announces its 2026 Annual Meeting of Shareholders, detailing proposals for director elections, executive compensation, auditor ratification, and a shareholder proposal on board leadership.

West Pharmaceutical Services, Inc. delivered robust financial performance in 2025 with over $3 billion in net sales and 8% adjusted-diluted EPS growth, while announcing CEO Eric Green's planned retirement in late 2026.